Showing results (351-360 of 966) with videos related to
Sort By:
Pageof 97
Acta Psychiatrica Scandinavica. Supplementum|December 6, 2007
Predicting clinical and social outcome of patients attending 'real world' mental health services: a 6-year multi-wave follow-up studyA Lasalvia, C Bonetto, D Cristofalo, et al.Acta Psychiatrica Scandinavica. Supplementum|December 6, 2007
Outcome of patients dropping out from community-based mental health care: a 6-year multiwave follow-up studyM Ruggeri, G Salvi, C Bonetto, et al.Acta Psychiatrica Scandinavica. Supplementum|October 24, 2007
Costs of schizophrenia during 5 yearsE Lindström, J Eberhard, M Neovius, et al.Acta Psychiatrica Scandinavica. Supplementum|October 19, 2007
Adjunctive treatment of acute mania: a clinical overviewG S Sachs, E E Gardner-SchusterActa Psychiatrica Scandinavica. Supplementum|October 19, 2007
Vascular mania: an old concept in danger of sclerosing? A clinical overviewC Wijeratne, G S MalhiActa Psychiatrica Scandinavica. Supplementum|October 19, 2007
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorderM Berk, S Dodd, M Kauer-Sant'anna, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemideM Da Prada, R Kettler, H H Keller, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depressionY Lecrubier, J D GuelfiActa Psychiatrica Scandinavica. Supplementum|January 1, 1990
Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in BelgiumG Beckers, A Vereecken, E de Bleeker, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patientsK Bizière, M BergerPageof 97